Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "atrophy" wg kryterium: Temat


Tytuł:
Coexistence of type 1 diabetes mellitus and spinal muscular atrophy in an 8-year-old girl: a case report
Autorzy:
Borkowska, Anna
Jankowska, Agnieszka
Szlagatys-Sidorkiewicz, Agnieszka
Sztangierska, Beata
Liberek, Anna
Plata-Nazar, Katarzyna
Kamińska, Barbara
Powiązania:
https://bibliotekanauki.pl/articles/1039156.pdf
Data publikacji:
2015
Wydawca:
Polskie Towarzystwo Biochemiczne
Tematy:
Spinal muscular atrophy
diabetes mellitus
children
Opis:
The spinal muscular atrophy is a rare autosomal recessive genetic disease characterized by the progressive loss of muscular strength. In its natural course the disease leads to death. Diabetes mellitus type 1 is an autoimmune metabolic disorder characterized by the disturbed insulin synthesis. This is a case report of an 8-year-old girl suffering from Werdnig Hoffman disease in whom DM1 was diagnosed. The unspecific clinical manifestation and diagnostic difficulties are presented in this paper. To the authors' knowledge, this is the first publication concerning the co-existence of these two medical conditions.
Źródło:
Acta Biochimica Polonica; 2015, 62, 1; 167-168
0001-527X
Pojawia się w:
Acta Biochimica Polonica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Comparative study of bioresorbable membranes „Collapan” and „Collost” for the prevention of lower jaw atrophy
Autorzy:
Pohodenko-Chudakova, I.
Maksimovich, K.
Powiązania:
https://bibliotekanauki.pl/articles/284482.pdf
Data publikacji:
2017
Wydawca:
Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie. Polskie Towarzystwo Biominerałów
Tematy:
bioresorbable membrane
alveolar bone atrophy
Collost
Collapan
Opis:
Prevention of the alveolar bone atrophy represents one of the urgent problems in oral and maxillofacial surgery. The aim of the study was comparative evaluation of two osteoplastic bioresorbable membranes: “Collapan” made of collagen type II, hydroxyapatite and gentamycin sulphate, and “Collost” made of collagen type I for prevention of the mandible atrophy. 42 male patients aged from 45 to 70 years were involved in the clinical trial. Group 1, which was the reference group, included 20 individuals, in whom “Collapan” membrane was implanted to prevent atrophy of the alveolar bone. Group 2 included 22 patients, in whom “Collost” membrane with the same purpose was used. Clinical efficacy was assessed by analysis of the number of complications in the postoperative period. The level of the alveolar bone atrophy was assessed at the long-term follow-up (after 1 year) based on the parameters of the mandibular bone tissue determined by cone-beam computed tomography. In the postoperative period in the group 1 there were revealed 6 (14%) cases of infectious-inflammatory complications – alveolitis, 2 (5%) of them were revealed after the third molar atypical removal and 4 (9%) after a complicated extraction of the tooth. In group 2 – 2 (5%) complications were reviled: 1 (2.5%) - alveolitis and 1 (2.5%) - forced tooth extraction. The use of the “Collost” membrane allowed maintaining the height of the alveolar bone in patients during the observation period. The results obtained in the trial allow us to conclude that the use of the osteoplastic bioresorbable membrane “Collost” is most appropriate for prevention of the alveolar part of the lower jaw atrophy.
Źródło:
Engineering of Biomaterials; 2017, 20, 142; 7-10
1429-7248
Pojawia się w:
Engineering of Biomaterials
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Detection of IL-1β, IL-6 and TNF-αin Sprague-Dawely rats’ atrophic thymus induced by lipopolysaccharide
Autorzy:
Zhong, Y.B.
Zhang, X.L.
Lv, M.Y.
Hu, X.F.
Li, Y.
Powiązania:
https://bibliotekanauki.pl/articles/2087664.pdf
Data publikacji:
2018
Wydawca:
Polska Akademia Nauk. Czytelnia Czasopism PAN
Tematy:
lipopolysaccharide
pro-inflammatory cytokines
thymus atrophy
rat
Źródło:
Polish Journal of Veterinary Sciences; 2018, 21, 3; 589-597
1505-1773
Pojawia się w:
Polish Journal of Veterinary Sciences
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Hyperglycemia induced C2C12 myoblast cell cycle arrest and skeletal muscle atrophy by modulating sirtuins gene expression in rats
Autorzy:
Surinlert, P.
Thitiphatphuvanon, T.
Khimmaktong, W.
Pholpramool, C.
Tipbunjong, C.
Powiązania:
https://bibliotekanauki.pl/articles/2087134.pdf
Data publikacji:
2021
Wydawca:
Polska Akademia Nauk. Czytelnia Czasopism PAN
Tematy:
diabetic mellitus
hyperglycemia
muscle atrophy
sirtuins
skeletal muscle
Źródło:
Polish Journal of Veterinary Sciences; 2021, 24, 4; 563-572
1505-1773
Pojawia się w:
Polish Journal of Veterinary Sciences
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Monitoring and evaluation of muscle atrophy: a much needed step in critically ill COVID-19 patients
Autorzy:
Kumar, Amarjeet
Kumar, Abhyuday
Kumar, Neeraj
Kumar, Ajeet
Sinha, Chandni
Kumari, Poonam
Singh, Veena
Powiązania:
https://bibliotekanauki.pl/articles/29432087.pdf
Data publikacji:
2021-03
Wydawca:
Towarzystwo Pomocy Doraźnej
Tematy:
COVID-ARDS
elderly
immobilization
muscle atrophy
noninvasive ventilation
Opis:
INTRODUCTION: Elderly COVID-19 patients admitted to the intensive care unit (ICU) are at high risk of an inflammatory syndrome, hypercatabolic reaction, malnutrition, and physical immobilization. This may result in loss of muscle mass and pulmonary infection leading to prolonged ventilatory support. Factors responsible for muscle mass loss in ICU are (1) microcirculatory disturbances, (2) presence of systemic inflammatory response syndrome (SIRS), (3) sepsis (4) drugs (corticoids, neuromuscular blockers) having inhibitory activity on the nervous system, neuromuscular junction and muscle itself. Mechanism of muscle atrophy in critically ill elderly patients include an imbalance between protein synthesis and degradation. Interventions to manage muscle atrophy for the patients admitted to ICU is also extrapolated to mechanically ventilated COVID-ARDS patients. PURPOSE: Early recognition of factors contributing to intensive care unit acquired weakness (ICUAW) in COVID-19 patients, inflammation, high catabolic phase, steroid use, and paralysis. The potential interventions to target these specific mechanisms and ameliorate muscle dysfunction in COVID-19 patients. CONCLUSIONS:Intensive care unit acquired weakness (ICUAW) in critically ill COVID-19 patients is due to severity of illness, co-morbidities, muscle unloading, or ICU treatments, a systemic reaction circulating within the body, or combinations therein. Furthermore, the availability of a culture model of ICUAW could facilitate in expediting the diagnosis of ICUAW and fast track the discovery of putative treatments. We recommend NIV or HFNC ventilation or early weaning from invasive mechanical ventilation in critically ill COVID-19 elderly patients.
Źródło:
Critical Care Innovations; 2021, 4, 1; 30-43
2545-2533
Pojawia się w:
Critical Care Innovations
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Repair of the peripheral nerve gap with epineural sheath conduit to prevent muscle denervation atrophy in the diabetic rat model
Autorzy:
Łukaszuk, Mirosław
Kwiecień, Grzegorz
Madajka, Maria
Uygur, Safak
Drews, Michał
Siemionow, Maria
Powiązania:
https://bibliotekanauki.pl/articles/1396247.pdf
Data publikacji:
2013-07-01
Wydawca:
Index Copernicus International
Tematy:
muscle denervation atrophy
peripheral nerve repair
diabetes
animal model
Opis:
Muscle denervation atrophy is a result of lower motor neuron injury, thus an early restitution of muscle stimulation is essential in prevention of atrophic changes. The aim of the study was to evaluate the new application of naturally occurring epineural sheath conduit in repair of the peripheral nerve gap to prevent development of muscle denervation atrophy. Material and methods. We used the model of 20 mm sciatic nerve gap, resulting in denervation atrophy of the gastrocnemius muscle in the diabetic rats (DM type 2, n=42, Zucker Diabetic Fatty strain). We applied the epineural sheath conduit created from the autologous sciatic nerve for gap repair. Muscle atrophy was assessed with the Gastrocnemius Muscle Index (GMI) and microscopic muscle morphometry (mean fiber area) at 6 and 12 postoperative week. Muscle regeneration in the experimental group was compared to the gold-standard technique of autologous nerve grafting for the repair of created nerve gap. Results. The GMI evaluation revealed comparable muscle mass restoration in groups with nerve repair using both epineural sheath and standard autologous nerve grafting (reaching 28 and 35% of contralateral muscle mass at 12 postoperative week, respectively, p=0.1), and significantly better restoration when compared to the negative control group (no repair, 20%, p<0.01). Micromorphometry confirmed significantly larger area of the regenerated muscle fibers in groups with both nerve grafting and epineural sheath conduit repair (reaching for both ca. 42% of the non-operated side), when compared to severe atrophic outcome when no nerve repair was performed (14% of the control fiber area, p<0.0001). The effectiveness of epineural conduit technique in muscle mass restoration was observed between 6 and 12 weeks after nerve repair - when gastrocnemius muscle mass increased by 12%. Conclusions. Peripheral nerve gap repair with naturally occurring epineural sheath conduit is effective in prevention of muscle denervation atrophy. This method is applicable in diabetic model conditions, showing results of regeneration which are comparable to the autologous nerve graft repair
Źródło:
Polish Journal of Surgery; 2013, 85, 7; 387-394
0032-373X
2299-2847
Pojawia się w:
Polish Journal of Surgery
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Zanik wieloukładowy typu C (MSA-C) – aspekty kliniczne i radiologiczne, opis przypadku
Clinical and radiological features of multiple system atrophy type C. Case report
Autorzy:
Węglewski, Arkadiusz
Juryńczyk, Jacek
Ślusarek, Izabela
Powiązania:
https://bibliotekanauki.pl/articles/1061185.pdf
Data publikacji:
2006
Wydawca:
Medical Communications
Tematy:
autonomic failure
cerebellar atrophy
magnetic resonance
multiple system atrophy
orthostatic hypotension
rezonans magnetyczny
zanik móżdżku
zanik wieloukładowy
niewydolność autonomiczna
hipotonia ortostatyczna
Opis:
Multiple system atrophy (MSA) is a relatively rare degenerative disease of the central nervous system. The prevalence of MSA is about 2-4/100,000. The disease is included to synucleinopathies. The most characteristic neuropathological findings in MSA is argyrophilic glial cytoplasmatic inclusions in oligodendroglia which is composed of α-synuclein and ubiquitin. At present two main forms of the MSA are known: MSA-P and MSA-C. Symptoms of parkinsonism with rigidity and bradykinesia are more typical in MSA-P. Cerebellar signs are more characteristic for MSA-C. Severe autonomic failure, initially or during further clinical course stwierin MSA-P and MSA-C is present in most patients. The main symptoms of autonomic failure are orthostatic hypotension, urinary and less commonly fecal incontinence, impotence. In 1998 consensus on the diagnosis of MSA was established. The authors described a case of 61-year-old woman with 3 years of symptoms of cerebellar dysfunction followed by Parkinson’s syndrome and autonomic failure. MRI of the brain revealed severe atrophy of the cerebellum and brain stem, and “hot cross bun sign” in pons. Tilt-test confirmed orthostatic hypotension. Treatment with L-dopa and midodrin was moderately effective. The authors described problems of diagnostics, especially role of MRI, and actual problems of epidemiology, pathogenesis and treatment of MSA.
Zanik wieloukładowy (MSA) jest rzadką chorobą zwyrodnieniową ośrodkowego układu nerwowego. Występuje z częstością ocenianą na 2-4/100.000 i zaliczany jest do synukleinopatii. Najbardziej charakterystyczną cechę neuropatologiczną stanowi obecność srebrnochłonnych wtrętów cytoplazmatycznych w komórkach oligodendrogleju, zawierających α-synukleinę i ubikwitynę. Obecnie wyróżnia się dwie główne formy MSA: MSA-P i MSA-C. W MSA-P dominują objawy parkinsonizmu, głównie sztywność, spowolnienie, a w MSA-C – objawy uszkodzenia móżdżku. W obu formach typowe są nasilone objawy dysfunkcji układu autonomicznego, głównie hipotonia ortostatyczna, zaburzenia zwieraczy oraz impotencja. W 1998 roku ustalono kryteria diagnostyczne MSA. Autorzy przedstawiają przypadek 61-letniej chorej z mniej więcej 3-letnim wywiadem zespołu móżdżkowego, do którego dołączyły się następnie objawy autonomiczne i parkinsonowskie. Badanie MR głowy ujawniło charakterystyczne dla formy MSA-C dużego stopnia zanik móżdżku, pnia mózgu oraz objaw „krzyża” w moście. Test pionizacyjny wskazał na ciężką hipotonię ortostatyczną. Leczenie L-dopą w umiarkowany sposób zmniejszyło nasilenie zespołu parkinsowskiego, a midodrinem – hipotonii ortostatycznej. Autorzy omawiają problemy diagnostyki MSA, ze szczególnym uwzględnieniem roli badania MR, oraz przedstawiają aktualny stan wiedzy na temat patogenezy, epidemiologii i terapii MSA.
Źródło:
Aktualności Neurologiczne; 2006, 6, 1; 48-53
1641-9227
2451-0696
Pojawia się w:
Aktualności Neurologiczne
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Can olive oil prevent distal colon mucosal atrophy caused by disuse in rats with colostomy? An experimental animal study
Autorzy:
Atıcı, Ahmet
Demir, Emel
Gürsoy, Didar
Çelikkaya, Mehmet
Akçora, Bülent
Powiązania:
https://bibliotekanauki.pl/articles/1391554.pdf
Data publikacji:
2021
Wydawca:
Index Copernicus International
Tematy:
children
distal colon mucosal atrophy caused by disuse
olive oil
Opis:
Aim: This study aims to investigate the effects of pure olive oil on mucosal atrophy of the distal colon in rats. Material and methods: The study included 28 male albino Wistar rats weighing 300–350 g. A total of 28 animals were randomly allocated to four groups: group 1: control group (n = 6); group 2: ostomy group (n = 6); group 3: ostomy + saline group (n = 8); group 4: ostomy + olive oil group (n = 8). By definition, group 1 did not undergo any procedure. The same surgical procedure was performed for groups 2, 3, and 4 as described below. In all animals from these groups, a two-centimeter-long mid-line incision was made and the colon was divided into 5 cm sections, measured from the distal colon to the caecum. Proximal and distal stomas were created 2 cm apart in the midline with the use of single-layer interrupted sutures. All rats were kept under close daily observation until they were terminated postoperatively after the 1st month. Animals from group 2 did not undergo any additional procedures, while those fromgroups 3 and 4 were given 2 mL of saline and olive oil twice a day, respectively. At the end of the 1st month, the rats were re-operated through the same approach. Biopsies were taken from the proximal and distal stomas of all rats in the same manner for further histopathological analysis. Results: Group 1 showed no significant differences in terms of mucosal thickness, muscular thickness, wall thickness or colonic lumen diameter between the proximal and distal segments of the colon. Although there were significant differences between the proximal and distal colostomies for each parameter in groups 2, 3, and 4, the mucosal thickness, muscular thickness, wall thickness, and colonic lumen diameter differences for proximal and distal ostomies were very small in group 4 when compared to groups 2 and 3. Conclusion: The administration of pure olive oil through the distal colon before colostomy closure may reduce the difference in diameter between the proximal and distal intestinal segments. As a result, a more straightforward surgical procedure may be achieved.
Źródło:
Polish Journal of Surgery; 2021, 93, 4; 35-40
0032-373X
2299-2847
Pojawia się w:
Polish Journal of Surgery
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
The application of High-Speed camera (HS), acoustic analysis and Voice Handicap Index (VHI) questionnaire in diagnosis of voice disorders in elderly men
Autorzy:
Kosztyła-Hojna, Bożena
Zdrojkowski, Maciej
Duchnowska, Emilia
Powiązania:
https://bibliotekanauki.pl/articles/1397805.pdf
Data publikacji:
2019
Wydawca:
Index Copernicus International
Tematy:
acoustic voice analysis
HSDI
hypofunctional dysphonia
presbyphonia
vocal fold atrophy
Opis:
Objective: The process of ageing begins after 60 years of age and is referred to as presbyphonia (Vox senium). The causes include functional or organic voice disorders, often coexisting with dry upper respiratory tract infection. Introduction: The aim of the study is the use of high-speed camera and acoustic voice analysis in diagnostics of the clinical form of presbyphonia. M aterials and methods: The study included a group of 50 men, non-smokers, age from 51 to 72, who do not use their voice professionally. High-Speed Digital Imaging and HS camera have been used, allowing evaluation of real vibrations of vocal folds, along with acoustic voice analysis using a software by DiagNova Technologies. Results: VHI questionnaire has been used for self-assessment of voice disability. Visualizations of the larynx enabled recognition of hypofunctional dysphonia or atrophy of vocal folds that cause voice disorders. This was confirmed by parameters of voice acoustic evaluation: F0, NHR, narrowband spectrography. The pathological value of NHR and the presence of nonharmonic components in the range of high frequency levels indicated glottal insufficiency, recorded with the visualization technique of the larynx by HS camera. A significant shortening of maximum phonation time in relation to the control group has also been recorded. Discussion: The objective examination of voice pathology is crucial in diagnosis and rehabilitation, however, subjective assessment of the patient is important in the scope of the procedure used. The patient’s subjective self-rating assessment (VHI) confirmed the sense of voice disorders in elderly men, indicating the need for rapid and accurate clinical diagnosis.
Źródło:
Polish Journal of Otolaryngology; 2019, 73, 5; 25-30
0030-6657
2300-8423
Pojawia się w:
Polish Journal of Otolaryngology
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Traumatic “TERSON SYNDROME PLUS”: Pneumocephalocele with optic atrophy
Autorzy:
Chowdhury, Sanjoy
Srivastava, Madhumita
Chowdhury, Nilanjan
Powiązania:
https://bibliotekanauki.pl/articles/2037682.pdf
Data publikacji:
2020-06-30
Wydawca:
Uniwersytet Rzeszowski. Wydawnictwo Uniwersytetu Rzeszowskiego
Tematy:
optic atrophy
sub retinal
subarachnoid hemorrhage
sub hyaloid
Terson syndrome plus
Opis:
Introduction. Terson Syndrome is subarachnoid hemorrhage (SAH) with sub retinal hemorrhage flowing through channel. Reduced vision in such fresh case is due to hemorrhage itself, blocking macula/other photo receptors in the long run macular cellophane retinopathy which causes profound visual loss. SAH causes neurological problems which can become a risk factor for evacuating blood from vitreous. Hypertension is commonest cause to cause Terson Syndrome, but trauma is also devastating cause as it can lead to irreversible visual consequences like total loss of perception of light or blindness. Aim. Here we describe a case of Terson Syndrome plus disease features SAH in frontal lobe. Description of the case. When there is traumatic pneumocephalocele, it gives space to blood to imbibe towards bony optic canal and form hematoma around nerve sheath which causes compression around the same and leads to optic atrophy. Optic nerve can be injured by direct traumatic dissection during road traffic accidents (RTA), but even without that blood may accumulate around optic nerve and in turn leads to formation of hematoma and subsequently pressure induced optic atrophy. Moreover, blood can slowly travel to sub hyaloid space/sub retinal space (beneath internal limiting membrane or sub ILM) with probable gliosis covering typical boat shaped blood as seen in this case. This sub ILM hemorrhage or gliosis may have resolved through three injections of Triamcinolone in the orbital floor (OFTA) near apex, but optic atrophy snatches vision. This protocol was followed to treat traumatic compressive (peri optic hematoma) optic neuropathy and traumatic retinopathy associated with sub hyaloid hemorrhage. Conclusion. Diagnosis of Terson syndrome plus disease was established by addressing all features on computed tomography (CT) scan and magnetic resonance imaging (MRI). Plus, features include pneumocephalus, optic nerve sheath hematoma, optic atrophy and gliosis over sub-hyaloid hemorrhage, typical boat shaped. The part of hemorrhage still endured as seen on optical coherence topography, but vision was lost by virtue of optic atrophy. OCT shows clot in sub hyaloid space
Źródło:
European Journal of Clinical and Experimental Medicine; 2020, 2; 116-120
2544-2406
2544-1361
Pojawia się w:
European Journal of Clinical and Experimental Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Speech therapy of a child with spinal muscular atrophy type 1 (SMA1): a case study
Terapia logopedyczna dziecka z rdzeniowym zanikiem mięśni typu 1 (SMA1). Studium przypadku
Autorzy:
Chilińska-Pułkowska, Alicja
Kaczorowska-Bray, Katarzyna
Powiązania:
https://bibliotekanauki.pl/articles/24201061.pdf
Data publikacji:
2021-06-29
Wydawca:
Wydawnictwo Uniwersytetu Śląskiego
Tematy:
SMA
SMA1
rdzeniowy zanik mięśni
terapia logopedyczna
spinal muscular atrophy
speech therapy
Opis:
The subject literature continues to lack descriptions of speech therapy of children with SMA1. The progressive character of the disease did not allow considerable progress to be made in therapy. However, currently available treatments bring about observable changes in patients in the sphere of activity of the speech apparatus, in the ability to receive food and swallow, as well as in respiratory activity. Making use of purposeful procedures and appropriate rehabilitation techniques, the speech therapist is able to attain positive effects and observe the development of functions which would decline without the medical support currently available. This article presents the case study of a child with SMA1. On the basis of appropriately selected diagnostic tools, an assessment was made of the child’s range of vocabulary and basic communicative skills, as well as sensorimotor evaluation of the oral-facial area. The article also discusses the activities undertaken during therapy and the rehabilitation techniques recognised as most significant and having the greatest effect.
W literaturze przedmiotu wciąż brakuje pozycji poświęconych terapii logopedycznej dziecka z SMA1. Postępujący charakter choroby nie pozwalał na uzyskiwanie zasadniczych postępów w terapii. Zmiany, jakie u pacjentów wywołuje dostępne dziś leczenie, są widoczne m.in. w sferze aktywności aparatu mowy, w zakresie umiejętności pobierania pokarmów i połykania oraz w czynnościach oddechowych. Logopeda jest w stanie, wykorzystując celowe postępowanie i odpowiednie techniki rehabilitacyjne, uzyskać pozytywne efekty swoich działań i obserwować rozwój funkcji, które bez dostępnego dziś wsparcia lekowego zanikałyby. W artykule zaprezentowano studium przypadku dziecka z SMA1. Na podstawie odpowiednio dobranych narzędzi diagnostycznych dokonano oceny zasobu słownictwa dziecka, bazowych umiejętności komunikacyjnych oraz oceny sensomotorycznej traktu ustno-twarzowego. Przedstawiono również podejmowane podczas terapii działania i techniki rehabilitacyjne, uznane za najistotniejsze i mające największy wpływ na jej efektywność.
Źródło:
Logopedia Silesiana; 2021, 10, 1; pp. 1-20: English language version; pp. 21-40: Polish language version
2300-5246
2391-4297
Pojawia się w:
Logopedia Silesiana
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Współczesny neofityzm polityczny na tle procesu komercjalizacji polityki
Modern-day political zeal and the process of politics commercialization
Autorzy:
Kilian, Stanisław
Powiązania:
https://bibliotekanauki.pl/articles/489660.pdf
Data publikacji:
2014
Wydawca:
Uniwersytet Pedagogiczny im. Komisji Edukacji Narodowej w Krakowie
Tematy:
political neophytism
political secularization
political parties articulation
function atrophy
medial hypnosis
civil religion
Opis:
The heuristic layer of the article includes the argumentation of the thesis that going to the opposite party and political reorientation based on an egoistic motive, called political neophytism, is becoming an impulse for the evolution of new political life forms and for the birth of new, hybrid political parties, which in turn are becoming a vivifying force of representative democracy, and which allow for keeping the quality of political life on a higher level, which can also be seen in the choice of legal-institutional solutions. In the public opinion the political conversion phenomenon is not gaining acceptation, for it is contrasting with the commonly accepted party loyalty rule and it bends the idea of political commitment, which is profiling the relations between the electorate and their deputies. Because of this some part of this electorate turns its back to political parties and transfers its expectations (and ruling authorization) to alternative subjects of common interest articulation, most commonly towards mass social movements. Others, in turn, feeling that they have been „cheated” by the neophyte, turn away from active political life completely and resign from taking part in the elections, others still turn to ideologically mutated historical parties which try to adopt the system of values and ideological cannons to the shifting socio-political conditions. In these groups there are the followers of radical parties with a clear ideology presented in the tradition and conservatism categories; the context of the way of thought of such a group can be used to analyze the election success of the Congress of the New Right – Janusz Korwin Mikke in the European Parliament election. It is also an important element of this presentation to prognose the changes in the political system under the phenomenon of political neophytism and similar behaviors, e.g. political mimicry.
Źródło:
Annales Universitatis Paedagogicae Cracoviensis. Studia Politologica; 2014, 13; 31-42
2081-3333
Pojawia się w:
Annales Universitatis Paedagogicae Cracoviensis. Studia Politologica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Kategoria dobra wspólnego jako podstawa dobrego państwa... w refleksji polskich środowisk katolickich
The common good as the basis of a good country in the context of the Polish Catholic enclaves
Autorzy:
Tasak, Agata
Powiązania:
https://bibliotekanauki.pl/articles/489889.pdf
Data publikacji:
2014
Wydawca:
Uniwersytet Pedagogiczny im. Komisji Edukacji Narodowej w Krakowie
Tematy:
political neophytism
political secularization
political parties articulation
function atrophy
medial hypnosis
civil religion
Opis:
The common good is one of the most important contexts in social and humanistic sciences and also incredibly difficult ones to undoubtedly define. Throughout many centuries, the meaning of this concept has been filled with different definitions. It is also one of the most important concepts to be defined in the Catholic social teachings. Following the Catholic social thought, it also inspires the Catholic secular communities, which are trying to give it a specific meaning in a given socio-political reality. The aim of the article is to explain how the Catholic communities in Poland are defining the meaning of this concept, how different they are in their description, and if their description is compliant with the directions of the Catholic Church. It can be said, all Catholic communities in Poland agree in this, that the notion of common good is one of the most important ones in the life of societies. All Catholic streams indicate that the citizens should be mobilized to define and complete the goals of the community, they also encourage Catholics to actively participate in the public life for the sake of the common good. All the streams underline that the most important goal of the existence of political rule should be to take steps to „take wise care of the common good”. What they are different in, though, is the perception of the gist of this good, and especially the way of its identification. The „open” stream of Catholicism, the dominant approach towards common good is the constructivist one. In the Catholic stream generally called „closed” the common good is described in the absolutistic approach. The understanding of the common good by the Catholic communities in Poland, though not diametrically different, indicates that there is a difference between these communities, and also adds new threads to its characteristic.
Źródło:
Annales Universitatis Paedagogicae Cracoviensis. Studia Politologica; 2014, 13; 43-61
2081-3333
Pojawia się w:
Annales Universitatis Paedagogicae Cracoviensis. Studia Politologica
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Nusinersen w leczeniu rdzeniowego zaniku mięśni – praca poglądowa
Nusinersen in the treatment of the spinal muscular atrophy
Autorzy:
Grędowska, Ewa
Modrzejewska, Sandra
Mazurkiewicz-Bełdzińska, Maria
Powiązania:
https://bibliotekanauki.pl/articles/1819287.pdf
Data publikacji:
2019
Wydawca:
Polskie Towarzystwo Neurologów Dziecięcych
Tematy:
Nusinersen
rdzeniowy zanik mięśni
oligo-nukleotyd antysensowny
spinal muscular atrophy
antisense oli-gonucleotide
Opis:
Nusinersen jest oligonukleotydem antysensownym wpływającym na alternatywny splicing genu SMN2, który wpływa na produkcję pełnowartościowego białka przeżycia neuronów ruchowych. W roku 2016 lek został zarejestrowany w leczeniu rdzeniowego zaniku mięśni (SMA) 5q w Stanach Zjednoczonych a w roku 2017 na obszarze Unii Europejskiej. Rdzeniowy zanik mięśni jest jedną z wiodących, genetycznych chorób będących przyczyną śmierci niemowląt. Choroba związana z dziedziczeniem autosomalnym recesywnym cechuje zapadalność na poziomie 10,3–13,5 przypadków na 100 000 żywych urodzeń. Do momentu rejestracji a później refundacji wąską grupę, 30 pacjentów leczono w Polsce, w ramach programu rozszerzonego dostępu do leku. Refundacja nusinersenu weszła w życie od 1. stycznia 2019 roku zapewniając pacjentom z SMA szeroki dostęp do leczenia, z możliwością włączenia pacjentów przedobjawowych i każdego typu SMA niezależnie od wieku i stanu funkcjonalnego. Kryteria leczenia pacjentów z SMA są ujęte w programie lekowym „Leczenie Rdzeniowego Zaniku Mięśni (B.102)”, na podstawie Obwieszczenia Ministra Zdrowia z dnia 27 grudnia 2018 r. Aktualnie w programie lekowym, na dzień 31 sierpnia 2019 jest leczonych 280 pacjentów.
Nusinersen is an antisense oligonucleotide that affects thealternative splicing of the SMN2 gene, hence the production of the fully functional survival motor neuron protein. In 2016, the drug was registered for the treatment of spinal muscularatrophy (SMA) 5q in the United States and in 2017 in the European Union. Spinal muscular atrophy is one of the leading genetic diseases that causes infants death. The disease associated with autosomal recessive inheritance is characterized by an incidence of 10.3–13.5 cases per 100,000 live births. Until registration and reimbursement, a narrow group of 30 patients was treated in Poland within expanded access program. The reimbursement of nusinersen was granted on January 1, 2019, providing SMA patients with wide access to treatment, with the option of including pre-symptomatic patients and any type of SMA; regardless of age or functional status. Criteria for the treatment of patients with SMA are outlined in the drug program “Treatment of Spinal Muscular Atrophy (B.102)”; based on the Health Minister Declaration from December 27, 2018.Currently, 280 patients are treated in the drug program as of August 31, 2019.
Źródło:
Neurologia Dziecięca; 2019, 28, 56; 17-21
1230-3690
2451-1897
Pojawia się w:
Neurologia Dziecięca
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Rdzeniowy zanik mięśni – onasemnogene abeparvovec i inne opcje terapeutyczne
Spinal muscular atrophy - onasemnogene abeparvovec and other therapeutic options
Autorzy:
Majchrzak-Celińska, Aleksandra A.
Warych, Anna
Szoszkiewicz, Mikołaj
Powiązania:
https://bibliotekanauki.pl/articles/762691.pdf
Data publikacji:
2020-02-25
Wydawca:
Polskie Towarzystwo Farmaceutyczne
Tematy:
rdzeniowy zanik mięśni
SMN1
SMN2
onasemnogene abeparvovec
nusinersen
spinal muscular atrophy
Opis:
Spinal muscular atrophy (SMA) is a neuromuscular disorder that results in the loss of motor neurons. SMA is caused by mutations in the SMN1 gene, leading to the decreased synthesis of the SMN protein, necessary for motor neuron survival. In the past, SMA was considered to be an incurable disease, and therapy was limited only to symptomatic treatment. However, currently there are drugs which effectively inhibit the development of the disease, and even give hope for its cure. Their mechanism of action involves either delivering of a functional copy of the SMN1 gene, or modification of the alternative splicing of the SMN2 gene. Moreover, amelioration of muscle growth and increasing muscle contractility serves as a way of relieving the symptoms of the disease. The functional copy of SMN1 gene is delivered by onasemnogene abeparvovec (Zolgensma). The drug contains cDNA sequences, which correspond to the missing SMN1 gene. It is administered in the form of adeno-associated viral vector serotype 9 (AAV9)–based gene therapy, as a single intravenous infusion, to treat children less than 2 years old. Currently, the drug is approved only in the USA, and its cost exceeds PLN 2,000,000. SMN2 has nearly identical sequence as SMN1, however due to alternative splicing, only around 10% of its transcript results in a full-length, functional SMN protein. Modification of the alternative splicing of the SMN2 pre-mRNA by the drug nusinersen (Spinraza) results in an increased level of the SMN protein. Nusinersen is administered as intrathecal injections and is available both in the USA as well as in Europe. Also risdiplam and branaplam - small-molecule drugs with similar mechanism of action are now being tested in clinical trials. The inhibition proMyostatin cleavage and slowing calcium release, leads to the increased muscle growth and contractility, respectively. So far, three promising drugs are being evaluated in clinical trials: SRK-015, which is a selective and local inhibitor of the activation of myostatin, as well as reldesemtiv (CK-2127107) and tirasemtiv (CK-2127107), both being the fast skeletal muscle troponin activators. These drugs do not affect the genetic cause of SMA, but relieve the symptoms of the disease. Early diagnosis and treatment gives hope for halting the progress of SMA, preserving motor function and extending patient’s life.
Rdzeniowy zanik mięśni (SMA) jest neurodegeneracyjną chorobą genetyczną, charakteryzującą się obumieraniem neuronów ruchowych. Przyczyną SMA są mutacje w genie SMN1, które skutkują niedoborem białka SMN. Niegdyś SMA uważane było za chorobę nieuleczalną, a terapia sprowadzała się do leczenia objawowego. Jednak obecnie dostępne są leki, które skutecznie hamują rozwój choroby, a wręcz dają nadzieję na jej wyleczenie. Ich mechanizm działania polega na dostarczeniu funkcjonalnej kopii genu SMN1, lub na zmodyfikowaniu składania transkryptu SMN2. Funkcjonalną kopię genu SMN1 dostarcza preparat onasemnogene abeparvovec (Zolgensma). Lek zawiera sekwencje cDNA, które odpowiadają prawidłowemu genowi SMN1 i podawany jest z wykorzystaniem kapsydu wirusa AAV9 jako nośnika w pojedynczej infuzji dożylnej. Leczeniem mogą być objęte dzieci do 2 roku życia. Obecnie lek zarejestrowany jest jedynie w USA, zaś koszt terapii przekracza 2 mln złotych. Gen SMN2 posiada sekwencję niemal identyczną z genem SMN1, jednak w wyniku alternatywnego składania pierwotnego transkryptu mRNA tego genu powstaje tylko ok. 10% funkcjonalnego białka SMN. Modyfikacja składania transkryptu genu SMN2 przez preparat nusinersen (Spinraza), zwiększa poziom funkcjonalnego białka SMN u leczonych nim chorych. Preparat podawany jest dooponowo. Leczenie możliwe jest zarówno w USA jak i na terenie Europy. Ponadto, testowane są również drobnocząsteczkowe leki o podobnym mechanizmie działania – risdiplam oraz branaplam. Stymulacja wzrostu mięśni oraz nasilenie ich kurczliwości stanowi również element terapii łagodzącej objawy choroby. Obecnie w fazie badań są trzy obiecujące związki: SRK-015, będący inhibitorem miostatyny, oraz reldesemtiv (CK-2127107) i tirasemtiv (CK-2127107), które są szybkimi aktywatorami troponiny. Wczesna diagnoza i podjęcie leczenia daje szansę na zahamowanie rozwoju SMA i tym samym utrzymanie sprawności motorycznej pacjenta oraz przedłużenie jego życia.
Źródło:
Farmacja Polska; 2020, 76, 1; 10-17
0014-8261
2544-8552
Pojawia się w:
Farmacja Polska
Dostawca treści:
Biblioteka Nauki
Artykuł

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies